ClinicalTrials.Veeva

Menu

Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Invitation-only

Conditions

Gestational Diabetes

Treatments

Other: 1 hour Blood glucose monitoring
Other: 2 hour blood glucose monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT05062460
20-10022829

Details and patient eligibility

About

The purpose of this study is to evaluate if in patients with gestational diabetes (GDM), adherence to postprandial glucose monitoring differs when performed 1-hour versus 2-hours after eating.

The primary objective of this study is to evaluate difference in rate of adherence (binary outcome defined as <80% or ≥80% of glucose log completed) between gestational diabetics who perform 1-hour versus 2-hour postprandial blood glucose testing.

Full description

Consented patients who are diagnosed with gestational diabetes will be randomized to either 1-hour or 2-hour postprandial blood glucose monitoring. A retrospective chart review from July 2020 until study commencement for patients from the same clinic will be used as a historical control group. This study will assess differences in adherence to testing.

Enrollment

140 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant patients with singleton gestation who are ≥ 18 years of age.
  • Diagnosis of GDM after 24 0/7 weeks.
  • For diagnosing GDM, a two-step screening algorithm will be performed according to the American College of Obstetrics and Gynecologists.4 Specifically, a 1-hour 50-g glucose-loading test is given first. Plasma glucose levels between 140 and 200 mg/dL will be considered elevated. Confirmatory testing will then be performed using a 3-hour 100-g glucose tolerance test. Diagnosis was made when two of the four values were elevated. Abnormal glucose value thresholds are established via the criteria suggested by Carpenter and Coustan: fasting value ≥ 95 mg/dL, 1-hour ≥ 180 mg/dL, 2-hour ≥ 155 mg/dL, and 3-hour ≥ 140 mg/dL.9 Patients with a blood glucose level greater than 200 mg/dL after 1-hour 50-g glucose-loading test will be diagnosed with GDM without requirement for the 3-hour 100-g glucose tolerance test.

Exclusion criteria

  • Type 1 pre-gestational diabetes
  • Type 2 pre-gestational diabetes
  • GDM diagnosed prior to 24 0/7 weeks gestation.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

140 participants in 2 patient groups

1-hour post-prandial blood glucose monitoring Arm
Other group
Description:
Arm in which participants are randomized to blood glucose monitoring at 1 hour after eating.
Treatment:
Other: 1 hour Blood glucose monitoring
2-hour post-prandial blood glucose monitoring Arm
Other group
Description:
Arm in which participants are randomized to blood glucose monitoring at 2 hours after eating.
Treatment:
Other: 2 hour blood glucose monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems